The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels
Proceedings of the National Academy of Sciences · 10.06.2025 · 122 (23)
DOI: 10.1073/pnas.2413811122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.06.2025. Verfasst von Yossef Maatuf und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel. Hauptthemen laut MEDLINE: Acetaminophen, Analgesics, Sodium Channel Blockers. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation (ISF), Israel Cancer Research Fund (ICRF).
Abstract (Originalsprache)
Paracetamol has been used for decades to relieve mild-to-moderate pain. Its analgesic effect is mainly attributed to its metabolite, AM404, acting on cannabinoid receptors or TRPV1 channels in central nervous system (CNS) neurons. Here, we show that AM404 is produced by primary sensory neurons. It inhibits sodium current in nociceptor neurons, blocking action potential (AP) generation and reducing nocifensive behavior in naïve and inflamed rats. We demonstrated that this analgesic effect of AM404 is mediated by its direct inhibition of nociceptive voltage-gated sodium channels (Na V ) 1.8 and 1.7 via the local anesthetic binding site. The Na V 1.8 and 1.7 inhibition was specific for AM404 and not observed with other metabolites of paracetamol. Our findings suggest that the analgesic effect of paracetamol is mediated mainly by direct AM404-induced inhibition of nociceptive sodium channels at the peripheral nociceptor neurons. Our findings lay a foundation for the potential development of AM404 as a selective local analgesic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.
- The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Jerusalem 911200, Israel.
- Mass Spectrometry Unit, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
ORCID-Profile: Yossef Maatuf, Yishai Kushnir, Mariana Ghantous, Ariel Iskimov, Alexander M Binshtok, Avi Priel
Förderung
- Israel Science Foundation (ISF)
- Israel Cancer Research Fund (ICRF)
Zitieren
APA
Maatuf, Y., Kushnir, Y., Nemirovski, A., Ghantous, M., Iskimov, A., Binshtok, A. M., & Priel, A. (2025). The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels. Proceedings of the National Academy of Sciences, 122(23). https://doi.org/10.1073/pnas.2413811122
Vancouver
Maatuf Y, Kushnir Y, Nemirovski A, Ghantous M, Iskimov A, Binshtok AM, et al. The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels. Proceedings of the National Academy of Sciences. 2025;122(23). doi:10.1073/pnas.2413811122
BibTeX
@article{Maatuf2025,
author = {Maatuf, Yossef and Kushnir, Yishai and Nemirovski, Alina and Ghantous, Mariana and Iskimov, Ariel and Binshtok, Alexander M and Priel, Avi},
title = {The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {23},
doi = {10.1073/pnas.2413811122}
}
EUVIMED